speb/financial-data huggingface dataset:
ISRG.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ISRG.TO income_statement (annual, 2023-12-31) — Tax Provision: 141600000.00
ISRG.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.07
ISRG.TO balance_sheet (annual, 2023-12-31) — Total Assets: 15441500000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 13307600000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 13397300000.00
ISRG.TO income_statement (annual, 2023-12-31) — Total Expenses: 5357300000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2044200000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 7553500000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 385500000.00
ISRG.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 1766800000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 111400000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 233800000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Work In Process: 159900000.00
ISRG.TO balance_sheet (annual, 2023-12-31) — Working Capital: 6229300000.00
ISRG.TO balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -1811500000.00
ISRG.TO balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 1428500000.00
ISRG.TO balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 1583500000.00
ISRG.TO balance_sheet (quarterly, 2024-09-30) — Gross PPE: 6244500000.00
ISRG.TO balance_sheet (quarterly, 2024-09-30) — Land And Improvements: 464100000.00
ISRG.TO balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 1313300000.00
ISRG.TO cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 9400000.00
ISRG.TO balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
ISRG.TO balance_sheet (quarterly, 2024-09-30) — Receivables Adjustments Allowances: -23600000.00
ISRG.TO income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -93700000.00
ISRG.TO income_statement (annual, 2024-12-31) — +Operating Expense: 3285300000.00
ISRG.TO income_statement (annual, 2024-12-31) — +Total Revenue: 8352100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 193400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1225400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1881300000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1881300000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 9681300000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -30700000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -30700000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 54400000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 54400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 4819100000.00
ISRG.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 8882358266.00
ISRG.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 8912366233.00
ISRG.TO income_statement (annual, 2024-12-31) — Basic EPS: 0.26
ISRG.TO income_statement (quarterly, 2024-12-31) — Basic EPS: 0.08
ISRG.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2770100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 1486300000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 1486300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -1111200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2027400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 4013300000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Cash Equivalents: 1548000000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 479400000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 150900000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -3272800000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 2415000000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: -400000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Inventory: -830000000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 108300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 130500000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Payable: -400000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -400000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -231800000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -95900000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -919300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -95900000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Changes In Cash: -706900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Common Stock: 400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 16433700000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 1631600000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1631600000.00
ISRG.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 2717900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 393100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Current Assets: 7111000000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 468800000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 468800000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 1745300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -135300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -135300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Depreciation: 445300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 499700000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 499700000.00
ISRG.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 9052403413.00
ISRG.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 9099916028.00
ISRG.TO income_statement (annual, 2024-12-31) — Diluted EPS: 0.26
ISRG.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.08
ISRG.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 2322600000.00
ISRG.TO income_statement (annual, 2024-12-31) — EBIT: 2348900000.00
ISRG.TO income_statement (annual, 2024-12-31) — EBITDA: 2848600000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -800000.00
ISRG.TO cash_flow (annual, 2024-12-31) — End Cash Position: 2062400000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 150900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 717600000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 1303800000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -43300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -1100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -51300000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Goodwill: 347500000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 370500000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 1256100000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 1256100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 6527900000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 6527900000.00
ISRG.TO income_statement (annual, 2024-12-31) — Gross Profit: 5634200000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 466500000.00
ISRG.TO income_statement (annual, 2024-12-31) — Interest Income: 324900000.00
ISRG.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 324900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Inventory: 1487200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 16433700000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -3272800000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 4819100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 4819100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 476400000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 476400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1354500000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1354500000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 95900000.00
ISRG.TO income_statement (annual, 2024-12-31) — Minority Interests: -14900000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -1000000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
ISRG.TO income_statement (annual, 2024-12-31) — Net Income: 2322600000.00
ISRG.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 2322600000.00
ISRG.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 2337500000.00
ISRG.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 2322600000.00
ISRG.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 2322600000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 2337500000.00
ISRG.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 2337500000.00
ISRG.TO income_statement (annual, 2024-12-31) — Net Interest Income: 324900000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -2160600000.00
ISRG.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 324900000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -278500000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Net PPE: 4646600000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1111200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 16063200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 1045100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 54100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 54100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 1045100000.00
ISRG.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 2848600000.00
ISRG.TO income_statement (annual, 2024-12-31) — Normalized Income: 2322600000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 2415000000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -44400000.00
ISRG.TO income_statement (annual, 2024-12-31) — Operating Income: 2348900000.00
ISRG.TO income_statement (annual, 2024-12-31) — Operating Revenue: 8352100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 356600000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 253700000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -51300000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 23000000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 37700000.00
ISRG.TO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 10700000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 750900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 175200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Other Properties: 1579100000.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 1579100000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 131400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1985900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Payables: 347800000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 740900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 535600000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
ISRG.TO income_statement (annual, 2024-12-31) — Pretax Income: 2673800000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 429400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
ISRG.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ISRG.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: -1000000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -5139600000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1111200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 563900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Receivables: 1356800000.00
ISRG.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 2717900000.00
ISRG.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 499700000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
ISRG.TO income_statement (annual, 2024-12-31) — Research And Development: 1145300000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 6803300000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 2979000000.00
ISRG.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 2140000000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Share Issued: 356600000.00
ISRG.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 676800000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 16433700000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 16063200000.00
ISRG.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ISRG.TO income_statement (annual, 2024-12-31) — Tax Provision: 336300000.00
ISRG.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.13
ISRG.TO balance_sheet (annual, 2024-12-31) — Total Assets: 18743200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 16433700000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 16529600000.00
ISRG.TO income_statement (annual, 2024-12-31) — Total Expenses: 6003200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2213600000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 11632200000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 468300000.00
ISRG.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 2348900000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 154400000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 239000000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Work In Process: 205700000.00
ISRG.TO balance_sheet (annual, 2024-12-31) — Working Capital: 5365700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 879600000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 2253400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 276200000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1090500000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 9993700000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 12100000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 12100000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 4589900000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 8939873536.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.08
ISRG.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2062400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -116600000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2573800000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4511300000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 1996500000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 577300000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -235800000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 213500000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 581600000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 83100000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -226000000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -211100000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -118100000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 37000000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 83100000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -142900000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -7800000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3600000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -439300000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 3600000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 559300000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 17106400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 795700000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 397900000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 7657800000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 496300000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 496300000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1538100000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 100000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 100000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 137500000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 149600000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 149600000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 9117420675.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.08
ISRG.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 698400000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — EBIT: 578100000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — EBITDA: 727700000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -4500000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 2617200000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -235800000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 773700000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 465000000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -17700000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -27100000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 347500000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 367100000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 1457700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Interest Income: 90400000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 90400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 1553600000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 17106400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 213500000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 4589900000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 4589900000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 101300000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Minority Interests: -5300000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Net Income: 698400000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 698400000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 703700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 698400000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 698400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 703700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 703700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 90400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 330100000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 90400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -370100000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 4799000000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -116600000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 16739300000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1038600000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 63600000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 63600000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1038600000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 727700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 698400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 581600000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -17700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Operating Income: 578100000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 2253400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 358400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 243500000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -27100000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 19600000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 8700000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 768000000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 179200000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 282900000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1937500000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Payables: 334200000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 732100000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 309700000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 668500000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 134300000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -519800000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -116600000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 549700000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 1349400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -24000000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 795700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 149600000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Research And Development: 316200000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 7139400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 849900000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 563400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 358400000.00
ISRG.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 185200000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 17106400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 16739300000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Tax Provision: -35200000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 19220400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 17106400000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 17207700000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 1675300000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2012700000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 11562600000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 474600000.00
ISRG.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 578100000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 58000000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 231800000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Work In Process: 230200000.00
ISRG.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 6119700000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 874500000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 2440000000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 266800000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1132000000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 10236800000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 12300000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 12300000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 4206000000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 8964880176.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.07
ISRG.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2617200000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -155300000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3403100000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 5326500000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 2875100000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 528000000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -147800000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 260700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 715400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -10700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 111100000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -283100000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 82400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 11800000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -10700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 100400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -134000000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -47700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -270200000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -47700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 828300000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 17845700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -181000000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 822100000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 411400000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 8745900000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 499900000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 499900000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1692600000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -29500000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -29500000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 152100000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 164400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 164400000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 9104917356.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.07
ISRG.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 658400000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — EBIT: 743400000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — EBITDA: 907800000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1000000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 3446500000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -147800000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 910800000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 560100000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -9700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 0.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 3000000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 348700000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 366600000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 1617900000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Interest Income: 88700000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 88700000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 1667000000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 17845700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 260700000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 4206000000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 4206000000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 107400000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -5800000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -1200000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -181000000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Net Income: 658400000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 658400000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 664200000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 658400000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 658400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 664200000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 664200000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 88700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 417200000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 88700000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -16200000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 4985300000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -155300000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 17479100000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 1070300000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 71800000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 71800000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1070300000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 907800000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 658400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 715400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -9700000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Operating Income: 743400000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 2440000000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 358418255.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 358200000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 3000000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 17900000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 9100000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 789100000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 195800000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 285100000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 1923400000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Payables: 360500000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 771900000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 420800000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 832100000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 49400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -1200000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -172000000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -155300000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 525400000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 1394200000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -22900000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 822100000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 164400000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -181000000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Research And Development: 313300000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 7605500000.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 589200000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 561200000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 358418255.00
ISRG.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 196200000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 17845700000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 17479100000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 167900000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.20
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 20163200000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 17845700000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 17953100000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 1696600000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2210100000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 11417300000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 517500000.00
ISRG.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 743400000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 93700000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 249900000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Work In Process: 230800000.00
ISRG.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 7053300000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 902700000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 2505100000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 291200000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1120000000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 10478800000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: -14500000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: -14500000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 3523700000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 3446500000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -105400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2806600000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 4908800000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 2233900000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 572700000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1843000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 401000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 841000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 24600000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 34700000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -316200000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 40900000.00